Scientific ReportsMolecular BiologyPeer-reviewed journal article
Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity
Joaquín Pérez‐SchindleriD, Elyzabeth Vargas‐Fernández, Bettina Karrer‐Cardel, Danilo RitziD, Alexander SchmidtiD, Christoph HandschiniD
Abstract
Non-alcoholic fatty liver disease is a continuum of disorders among which non-alcoholic steatohepatitis (NASH) is particularly associated with a negative prognosis. Hepatocyte lipotoxicity is one of the main pathogenic factors of liver fibrosis and NASH. However, the molecular mechanisms regulating this process are poorly understood. The main aim of this study was to dissect transcriptional mechanisms regulated by lipotoxicity in hepatocytes. We achieved this aim by combining transcriptomic, proteomic and chromatin accessibility analyses from human liver and mouse hepatocytes. This integrative approach revealed several transcription factor networks deregulated by NASH and lipotoxicity. To validate these predictions, genetic deletion of the transcription factors MAFK and TCF4 was performed, resulting in hepatocytes that were better protected against saturated fatty acid oversupply. MAFK- and TCF4-regulated gene expression profiles suggest a mitigating effect against cell stress, while promoting cell survival and growth. Moreover, in the context of lipotoxicity, some MAFK and TCF4 target genes were to the corresponding differentially regulated transcripts in human liver fibrosis. Collectively, our findings comprehensively profile the transcriptional response to lipotoxicity in hepatocytes, revealing new molecular insights and providing a valuable resource for future endeavours to tackle the molecular mechanisms of NASH.
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- assay: proteomics
- assay: ChIP-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 7
- FWCI
- 1.26
- Field percentile
- top 24%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A network-based approach reveals the dysregulated transcriptional regulation in non-alcohol fatty liver disease
Hong Yang, Muhammad Arif, … Adil Mardinoğlu·iSciencePeer-reviewed·Oct 5, 2021
- Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor
J. Personnaz, E. Piccolo, … J.-P. Pradere·bioRxiv·Feb 17, 2021
- Autocrine IL11 cis-signaling in hepatocytes is an initiating nexus between lipotoxicity and non-alcoholic steatohepatitis
Jinrui Dong, Sivakumar Viswanathan, … Anissa Anindya Widjaja·Nature CommunicationsPeer-reviewed·Jan 4, 2021
- FLCN Gene Ablation Reduces Fibrosis and Inflammation in a Diet-Induced NASH Model
M. Paquette, M. Yan, … A. Pause·bioRxiv·Sep 10, 2020
- FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis
C. Liu, M. Schönke, … P. C. Rensen·bioRxiv·Sep 20, 2022
- Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis
C. Patitucci, J. D. Hernandez Camacho, … T. Wai·bioRxiv·Apr 26, 2023